Occurrence and fate of antibiotic, analgesic/anti-inflammatory, and antifungal compounds in five wastewater treatment processes

Science of the Total Environment

Volumn 473-474, Issue , 2014, Pages 235-243

  Guerra, P ^a   Kim, M ^a   Shah, A ^a   Alaee, M ^a   Smyth, S A ^a  

^a ENVIRONMENT CANADA   (Canada)

Author keywords

Biosolids; Personal care products; Pharmaceuticals; Sludge; Wastewater

Indexed keywords

ACTIVATED SLUDGE PROCESS; ANTIBIOTICS; BIODEGRADATION; BIOLOGICAL MATERIALS; BIOSOLIDS; DRUG PRODUCTS; FUNGI; RECLAMATION; WASTEWATER; WASTEWATER TREATMENT;

ANTIFUNGAL COMPOUNDS; BIOLOGICAL NUTRIENT REMOVAL; BIOLOGICAL TREATMENT; PERSONAL CARE PRODUCTS; PHARMACEUTICALS AND PERSONAL CARE PRODUCTS; SLUDGE; WASTEWATER TREATMENT PLANTS; WASTEWATER TREATMENT PROCESS;

EFFLUENTS;

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; SURFACE WATER;

ACTIVATED SLUDGE; ANTIBIOTICS; BIODEGRADATION; BIOSOLID; DISCHARGE; DRUG; EFFLUENT; ENVIRONMENTAL FATE; POLLUTANT REMOVAL; WASTE TREATMENT; WASTEWATER;

ACTIVATED SLUDGE; ARTICLE; BIODEGRADATION; BIOMASS; CANADA; CHEMICAL OXYGEN DEMAND; HYDROPHOBICITY; LIQUID CHROMATOGRAPHY; NITRIFICATION; PERSONAL HYGIENE; PRIORITY JOURNAL; SEASONAL VARIATION; SURFACE PROPERTY; SUSPENDED PARTICULATE MATTER; TANDEM MASS SPECTROMETRY; WASTE COMPONENT REMOVAL; WASTE WATER MANAGEMENT; WATER ANALYSIS;

BIOSOLIDS; PERSONAL CARE PRODUCTS; PHARMACEUTICALS; SLUDGE; WASTEWATER;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIFUNGAL AGENTS; ENVIRONMENTAL MONITORING; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84890926266     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2013.12.008     Document Type: Article

References (46)

1. APHA Standards methods for the examination of water and wastewater 2005, APHA-AWWA-WEF, Washington D.C.
2. Bedoux G., Roig B., Thomas O., Dupont V., Le Bot B. Occurrence and toxicity of antimicrobial triclosan and by-products in the environment. Environ Sci Pollut Res 2012, 19:1044-1065.
3. Behera S.K., Kim H.W., Oh J.E., Park H.S. Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea. Sci Total Environ 2011, 409:4351-4360.
4. Brausch J.M., Connors K.A., Brooks B.W., Rand G.M. Human pharmaceuticals in the aquatic environment: a review of recent toxicological studies and considerations for toxicity testing 2012, 218:1-99. Whitacre, D. M.
5. Brausch J.M., Rand G.M. A review of personal care products in the aquatic environment: environmental concentrations and toxicity. Chemosphere 2011, 82:1518-1532.
6. Brodin T., Fick J., Jonsson M., Klaminder J. Dilute concentrations of a psychiatric drug alter behavior of fish from natural populations. Science 2013, 339:814-815.
7. Brun G.L., Bernier M., Losier R., Doe K., Jackman P., Lee H.B. Pharmaceutically active compounds in Atlantic Canadian sewage treatment plant effluents and receiving waters, and potential for environmental effects as measured by acute and chronic aquatic toxicity. Environ Toxicol Chem 2006, 25:2163-2176.
8. Castiglioni S., Bagnati R., Fanelli R., Pomati F., Calamari D., Zuccato E. Removal of pharmaceuticals in sewage treatment plants in Italy. Environ Sci Technol 2006, 40:357-363.
9. Conkle J.L., White J.R., Metcalfe C.D. Reduction of pharmaceutically active compounds by a lagoon wetland wastewater treatment system in Southeast Louisiana. Chemosphere 2008, 73:1741-1748.
10. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ Health Perspect 1999, 107:907-938.
11. Du B., Price A.E., Scott W.C., Kristofco L.A., Ramirez A.J., Chambliss C.K., et al. Comparison of contaminants of emerging concern removal, discharge, and water quality hazards among centralized and on-site wastewater treatment system effluents receiving common wastewater influent. Sci Total Environ 2014, 466-467:976-984.
12. Fatta-Kassinos D., Meric S., Nikolaou A. Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research. Anal Bioanal Chem 2011, 399:251-275.
13. Gagnon C., Lajeunesse A., Cejka P., Gagnon F., Hausler R. Degradation of selected acidic and neutral pharmaceutical products in a primary-treated wastewater by disinfection processes. Ozone: Sci Eng 2008, 30:387-392.
14. Gao L., Shi Y., Li W., Niu H., Liu J., Cai Y. Occurrence of antibiotics in eight sewage treatment plants in Beijing, China. Chemosphere 2012, 86:665-671.
15. Gobel A., McArdell C.S., Joss A., Siegrist H., Giger W. Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. Sci Total Environ 2007, 372:361-371.
16. Gobel A., Thomsen A., McArdell C.S., Joss A., Giger W. Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environ Sci Technol 2005, 39:3981-3989.
17. Heidler J., Halden R.U. Mass balance assessment of triclosan removal during conventional sewage treatment. Chemosphere 2007, 66:362-369.
18. Heidler J., Halden R.U. Meta-analysis of mass balances examining chemical fate during wastewater treatment. Environ Sci Technol 2008, 42:6324-6332.
19. Heidler J., Sapkota A., Halden R.U. Partitioning, persistence, and accumulation in digested sludge of the topical antiseptic triclocarban during wastewater treatment. Environ Sci Technol 2006, 40:3634-3639.
20. IMS Health Canada Unlocking the value of health information 2012, [In: www.imshealthcanada.com visited on 11-13-2012].
21. Jelic A., Gros M., Ginebreda A., Cespedes-Sanchez R., Ventura F., Petrovic M., et al. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Res 2011, 45:1165-1176.
22. Jia A., Wan Y., Xiao Y., Hu J. Occurrence and fate of quinolone and fluoroquinolone antibiotics in a municipal sewage treatment plant. Water Res 2012, 46:387-394.
23. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Res 2009, 43:363-380.
24. Kraigher B., Mandic-Mulec I. Nitrification activity and community structure of nitrite-oxidizing bacteria in the bioreactors operated with addition of pharmaceuticals. J Hazard Mater 2011, 188:78-84.
25. Langford K.H., Reid M., Thomas K.V. Multi-residue screening of prioritised human pharmaceuticals, illicit drugs and bactericides in sediments and sludge. J Environ Monit 2011, 13:2284-2291.
26. Langford K.H., Thomas K.V. Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works. Environ Int 2009, 35:766-770.
27. Le-Minh N., Khan S.J., Drewes J.E., Stuetz R.M. Fate of antibiotics during municipal water recycling treatment processes. Water Res 2010, 44:4295-4323.
28. Li B., Zhang T. Biodegradation and adsorption of antibiotics in the activated sludge process. Environ Sci Technol 2010, 44:3468-3473.
29. Lin A.Y.C., Yu T.H., Lateef S.K. Removal of pharmaceuticals in secondary wastewater treatment processes in Taiwan. J Hazard Mater 2009, 167:1163-1169.
30. Lindberg R.H., Wennberg P., Johansson M.I., Tysklind M., Andersson B.A.V. Screening of human antibiotic substances and determination of weekly mass flows in five sewage treatment plants in Sweden. Environ Sci Technol 2005, 39:3421-3429.
31. Lishman L., Smyth S.A., Sarafin K., Kleywegt S., Toito J., Peart T., et al. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario. Can Sci Total Environ 2006, 367:544-558.
32. MacLeod S.L., Wong C.S. Loadings, trends, comparisons, and fate of achiral and chiral pharmaceuticals in wastewaters from urban tertiary and rural aerated lagoon treatments. Water Res 2010, 44:533-544.
33. McClellan K., Halden R.U. Pharmaceuticals and personal care products in archived U.S. biosolids from the 2001 EPA national sewage sludge survey. Water Res 2010, 44:658-668.
34. Monteiro S.C., Boxall A.B.A. Occurrence and fate of human pharmaceuticals in the environment. Rev Environ Contam Toxic 2010, 202:53-154.
35. Ort C., Lawrence M.G., Reungoat J., Eaglesham G., Carter S., Keller J. Determining the fraction of pharmaceutical residues in wastewater originating from a hospital. Water Res 2010, 44:605-615.
36. Ort C., Lawrence M.G., Rieckermann J., Joss A. Sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in wastewater systems: are your conclusions valid? A critical review. Environ Sci Technol 2010, 44:6024-6035.
37. Richardson S.D., Ternes T.A. Water analysis: emerging contaminants and current issues. Anal Chem 2011, 83:4616-4648.
38. Statistics Canada A portrait of seniors in Canada http://www.statcan.gc.ca/pub/89-519-x/89-519-x2006001-eng.pdf.
39. Suarez S., Lema J.M., Omil F. Removal of Pharmaceutical and Personal Care Products (PPCPs) under nitrifying and denitrifying conditions. Water Res 2010, 44:3214-3224.
40. US EPA Sampling procedures and protocols for the National Sewage Sludge Survey 1988, United States Environmental Protection Agency.
41. US EPA Method 1694: pharmaceuticals and personal care products in water, soil, sediment, and biosolids by HPLC/MS/MS 2007, United States Environmental Protection Agency.
42. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment-A review. Sci Total Environ 2012, 429:123-155.
43. Wells M.J.M. Log DOW: key to understanding and regulating wastewater-derived contaminants. Environ Chem 2006, 3:439-449.
44. Wick A., Wagner M., Ternes T.A. Elucidation of the transformation pathway of the opium alkaloid codeine in biological wastewater treatment. Environ Sci Technol 2011, 45:3374-3385.
45. Yang X., Flowers R.C., Weinberg H.S., Singer P.C. Occurrence and removal of pharmaceuticals and personal care products (PPCPs) in an advanced wastewater reclamation plant. Water Res 2011, 45:5218-5228.
46. Ziylan A., Ince N.H. The occurrence and fate of anti-inflammatory and analgesic pharmaceuticals in sewage and fresh water: treatability by conventional and non-conventional processes. J Hazard Mater 2011, 187:24-36.